Findings identify strategy for boosting anticancer immunity and potentially a new tool for delivering genetic payloads to ...

Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

Shifting brain glucose levels act as a metabolic switch that directs OPC proliferation and myelin formation, revealing a mechanism with developmental and clinical implications.

By deploying a "tag and sort" fix using E3 ligases, scientists successfully cleared the protein buildup and restored T-cell ...

j. Craig Venter, PhD [Heather Kowalski] J. Craig Venter, PhD, the founder, board chair, and CEO of the J. Craig Venter Institute (JCVI) has died in San Diego following a brief hospitalization for ...

Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

Study finds that a classically anaerobic bacterium, ETBF, can benefit from, and even help create, an oxygen-rich environment.

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...

IDT played a pivotal role in manufacturing the personalized gene editing therapy given to baby KJ Muldoon to treat his rare ...

New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...

As more products reach the market, therapy developers partner with researchers and regulators to deliver N-of-1 treatments to patients.